A description of the development of an innovative multi-component long COVID treatment program based on central sensitization with preliminary patient satisfaction data.

Patient satisfaction measures were high for the sample at the end of the treatment program suggesting that a multicomponent treatment program targeting Central Sensitization is acceptable to patients. Further research is needed to explore the effectiveness and durability of this treatment approach.